← Leaderboards
Michelle Alyssa Tran
Icahn School Of Medicine At Mount Sinai
$201,198
Attributed
$201,198
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54.5K · FY2022–25$100K$75K$50K$25K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$201,198 · 1
By mechanism
F30$201,198 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Miriam Merad$28,468,631
- Emma Guttman$8,500,791
- Andrew Sikora$5,297,462
- Ana Fernandez-Sesma$24,867,465
- Jordi Ochando$5,634,948
Others in their field
Other Rising Stars on “Accounting”
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Cathie Snyder · Rho Federal Systems Division, Inc.$13,500,724
- Chris Maxwell · National Institute Of Allergy And Infectious Diseases$12,000,000
- Mariet Allen · Mayo Clinic Jacksonville$9,602,417
- Peter N. Schmidt · Rho Federal Systems Division, Inc.$8,977,742
- Anne L Wiper · The Industrial Commons$4,568,097
Research focus
AccountingAdaptive ImmunityAdaptive Immune ResponseAntigen PresentationAnti-Pd1 AntibodiesAtlasesAutologousAngiogenesisBiologicalBladder NeoplasmBloodCancer PatientCd8-Positive T-LymphocytesCell PhysiologyCellsCellular Indexing Of Transcriptomes And Epitopes By SequencingCessation Of LifeChemokineClinical BiomarkersClinical PredictorsClinical TrialsCoculture TechniquesCohortCoin
Grant awards (4)
Dissecting innate immune mechanisms of resistance to checkpoint blockade therapy in bladder cancer$54,538
F30 · FY2025 · CA · contact PI
Dissecting innate immune mechanisms of resistance to checkpoint blockade therapy in bladder cancer$53,974
F30 · FY2024 · CA · contact PI
Dissecting innate immune mechanisms of resistance to checkpoint blockade therapy in bladder cancer$46,094
F30 · FY2023 · CA · contact PI
Dissecting innate immune mechanisms of resistance to checkpoint blockade therapy in bladder cancer$46,592
F30 · FY2022 · CA · contact PI